SAN RAFAEL, Calif.,
Aug. 15, 2017 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today
announced that management will participate in Citi's Annual Biotech
Conference on September 6, 2017 in
Boston, Baird's 2017 Global
Healthcare Conference on September 7,
2017 in New York and the
Morgan Stanley 15th Annual Global Healthcare Conference
on September 12, 2017 in New
York. For information about webcasting, please visit the
investor section of the BioMarin website, www.biomarin.com. A
replay of all webcasts will also be archived on the site for at
least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for people with serious and
life-threatening rare disorders. The company's portfolio consists
of six commercialized products and multiple clinical and
pre-clinical product candidates.
For additional information, please visit www.biomarin.com.
Information on BioMarin's website is not incorporated by reference
into this press release.
|
Contacts:
|
|
|
Investors
|
Media
|
|
Traci
McCarty
|
Debra
Charlesworth
|
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
|
(415)
455-7558
|
(415)
455-7451
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/biomarin-to-attend-upcoming-investor-conferences-300504281.html
SOURCE BioMarin Pharmaceutical Inc.